Drug Design, Development and Therapy
Prior Use of GLP-1 Receptor Agonists versus SGLT2 Inhibitors and Clinical Outcomes After Sepsis in Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study
Cohort study of 11,969 peopleSepsis
Papers by Chi Huang
13 results
- Genetics in Medicine Open
Population-specific optimization of polygenic risk scores for breast cancer in East Asians
Cohort study of 46,422 peopleBreast cancer - Frontiers in Pharmacology
SGLT2 inhibitors and outcomes in the chronic Post-LVAD phase: a multicenter real-world cohort study
Cohort study in peopleSGLT2 inhibitors
- JACC Advances
PCSK9 Inhibitors and Risk of Aortic Stenosis in Atherosclerotic Cardiovascular Disease
Study in peopleInterventions - QJM
Association Between PCSK9 Inhibitor Use and Risk of Incident Heart Failure in Patients With Dyslipidemia
Cohort study of 40,098 peoplePCSK9 inhibitors - Journal of Lipid Research
Fecal metabolomic profiles by LDL-C target achievement status in statin-treated patients: a cross-sectional study
Cross-sectional study of 124 peopleAmino acid metabolism - Frontiers in Urology
Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy
Cohort study of 1,009 peopleGLP-1 receptor agonists - Frontiers in Pharmacology
Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study
Cohort study of 189,156 peopleCardiomyopathy - ADA Scientific Sessions 2026 Abstract
Urinary Post-translationally Modified Fetuin-A Predicts Renal Outcomes Independent of Albuminuria and eGFR in Type 2 Diabetes and CKD: CREDENCE Analysis
Trial in peopleBiomarkers - ADA Scientific Sessions 2026 Abstract
Independent Prognostic Value of the Novel Early Biomarker uPTM-FetA/Ucr in Diabetic Kidney Disease: Overcoming Treatment Confounders in a Real-World Cohort
Study in peopleBiomarkers